Quantum BioPharma Ltd
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.www.quantumbiopharma.com
6
MENTIONS
1
EPISODES
1
PODCASTS
Search complete. 6 mentions across 1 episode found for "Quantum BioPharma Ltd".
Sep 30, 2026
Carmel FisherHOST
Hi, and welcome to another revelatory episode here with me, Carmel Fischer.
Carmel FisherHOST
We're excited today to jump into some more details about Quantum Biopharma.
Carmel FisherHOST
They are listed on the NASDAQ exchange as QNTM.
Carmel FisherHOST
And with me today is co-founder and executive chairman, Mr. Anthony Durkacz.
Carmel FisherHOST
We are so excited to hear more from you today.
Anthony DurkaczGUEST
Thank you, Carmel.
Carmel FisherHOST
As a start, just tell us what Quantum Biopharma does.
Carmel FisherHOST
What is the main focus? And then in a nutshell, what has the last five years culminated and where are we going in the next, say, two?